← Back to Search
Preparation Of Azithromycin Nanosuspensions By High Pressure Homogenization And Its Physicochemical Characteristics Studies
Dianrui Zhang, T. Tan, L. Gao, Wenfa Zhao, P. Wang
Published 2007 · Medicine, Chemistry
Download PDFAnalyze on Scholarcy
ABSTRACT The azalide azithromycin was proved to be clinically effective against Gram-positive and Gram-negative bacteria. But the low bioavailability caused by its poor solubility and gastrointestinal response limited its application in clinic. With the purpose of increasing its saturation solubility and dissolution velocity, azithromycin was produced as nanosuspensions by high pressure homogenization. Nanosuspensions could increase the drug-loading and reduce the administration dosage, thus the gastrointestinal response could be minimized. In order to enhance the stability of the nanosuspensions, we got the freeze-dried powder by lyophilization. After dispersed in distilled water, the nanoparticles had a bulk population of about 400 nm and a spherical figure (watched by transmission electron microscopy). The analysis of differential scanning calorimetry and powder X-ray diffraction demonstrated that the crystal state of azithromycin had changed. In vitro release studies showed that the dissolution rate of nanosuspension, compared with micronized powder, had been obviously increased.
This paper references
Amorphous drug nanosuspensions. 1. Inhibition of Ostwald ripening.
Lennart Lindfors (2006)
Nanosuspensions for the formulation of poorly soluble drugs: I. Preparation by a size-reduction technique
R. Mueller (1998)
The effect of spray drying solutions of bendroflumethiazide/polyethylene glycol on the physicochemical properties of the resultant materials.
D. Corrigan (2003)
Development of an intravenously injectable chemically stable aqueous omeprazole formulation using nanosuspension technology.
J. Möschwitzer (2004)
The safety of azithromycin in the treatment of adults with community-acquired respiratory tract infections.
G. Treadway (2002)
Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisation.
C. Keck (2006)
Thermoanalysis of microspheres
C. Dubernet (1995)
Azithromycin: the first of the tissue-selective azalides.
I. Hoepelman (1995)
BIODEGRADABLE POLY (E-CAPROLACTONE) NANOPARTICLES FOR TUMOR-TARGETED DELIVERY OF TAMOXIFEN
J. S. Chawla (2002)
Buparvaquone mucoadhesive nanosuspension: preparation, optimisation and long-term stability.
R. Mueller (2002)
Preparation and evaluation of nanosuspensions for enhancing the dissolution of poorly soluble drugs.
P. Kocbek (2006)
Advanced-generation macrolides: tissue-directed antibiotics.
G. Amsden (2001)
Nanosuspensions of poorly soluble drugs--reproducibility of small scale production.
M. Grau (2000)
Comparison of the mechanical properties of the crystalline and amorphous forms of a drug substance.
Bruno C. Hancock (2002)
Nanosuspensions as particulate drug formulations in therapy. Rationale for development and what we can expect for the future.
R. Mueller (2001)
Production and characterisation of mucoadhesive nanosuspensions for the formulation of bupravaquone.
C. Jacobs (2001)
Lab-scale production unit design for nanosuspensions of sparingly soluble cytotoxic drugs.
This paper is referenced by
Leishmanicidal activity of amphotericin B encapsulated in PLGA-DMSA nanoparticles to treat cutaneous leishmaniasis in C57BL/6 mice.
Ricardo Fontoura de Carvalho (2013)
Non-ionic self-assembling amphiphilic polyester dendrimers as new drug delivery excipients
Dhiraj R. Sikwal (2017)
Evaluation of anti-hepatocarcinoma capacity of puerarin nanosuspensions against human HepG2 cells
Xiang-ping Meng (2017)
Stabilizers used in nanocrystal based drug delivery systems
G. Shete (2014)
Recent advances in the engineering of nanosized active pharmaceutical ingredients: Promises and challenges.
Waseem Kaialy (2016)
Nano strategies for berberine delivery, a natural alkaloid of Berberis.
Elaheh Mirhadi (2018)
Industrial concentrates of dermal hesperidin smartCrystals®--production, characterization & long-term stability.
Gregori B. Romero (2015)
In vivo evaluation of curcumin loaded nanosuspensions by oral administration.
Y. Gao (2012)
The role of particle size of glyburide crystals in improving its oral absorption
Y. Wang (2017)
Preparation of azithromycin microcapsules by a layer-by-layer self-assembly approach and release behaviors of azithromycin
Z. Zhang (2010)
Design and development of solid nanoparticulate dosage forms of telmisartan for bioavailability enhancement by integration of experimental design and principal component analysis
J. Patel (2014)
Preparation, characterization and pharmacokinetics of cyadox nanosuspension
Adeel Sattar (2017)
Investigation of various practical techniques to enhance dissolution of ezetimibe from oral tablets: A comparative study
Prema Kumari Nanam (2014)
Evaluation of improved oral bioavailability of ritonavir nanosuspension
A. Karakucuk (2019)
Evaluation of the parameters of a bead milling process to produce a non-aqueous nanosuspension
C. J. Ribeiro (2017)
Preparation, characterization, pharmacokinetics, and tissue distribution of curcumin nanosuspension with TPGS as stabilizer
Y. Gao (2010)
Nanosuspension Technology: Recent Patents on Drug Delivery and their Characterizations
Surya Goel (2019)
Solid Nanosuspensions: The Emerging Technology and Pharmaceutical Applications as Nanomedicine
S. Verma (2010)
Application of Drug Nanocrystal Technologies on Oral Drug Delivery of Poorly Soluble Drugs
L. Gao (2012)
Emulsion-templated synthesis and in vitro characterizations of niosomes for improved therapeutic potential of hydrophobic anti-cancer drug: tamoxifen
Hamid Saeed Shah (2019)
Investigation of the physico-chemical properties of amorphous solid-state forms of azithromycin
A. François Joubert (2016)
Physical and chemical stability of drug nanoparticles.
L. Wu (2011)
Freeze-drying of pharmaceutical and nutraceutical nanoparticles: The effects of formulation and technique parameters on nanoparticles characteristics.
M. Mohammady (2020)
Design and Evaluation of Novel Solid Self-Nanodispersion Delivery System for Andrographolide
Junnan Xu (2016)
Particle Engineering Technologies for Pulmonary Drug Delivery
N. El-gendy (2011)
In Vitro Antitumor Efficacy of Puerarin Nanosuspension against Human HepG2 Cells
W. L. Lu (2015)
Drug nanocrystals in the commercial pharmaceutical development process.
J. Möschwitzer (2013)
Nanocrystal Preparation: Low-Energy Precipitation Method Revisited
Shahzeb Khan (2013)
NANOPRECIPITATION TECHNIQUE FOR PREPARATION OF STERICALLY STABILIZED RISPERIDONE NANOSUSPENSION: IN VITRO AND IN VIVO STUDY
H. Salem (2016)
Drug nanocrystals for the formulation of poorly soluble drugs and its application as a potential drug delivery system
L. Gao (2008)
Development of nanosuspension formulation for oral delivery of quercetin.
M. Sun (2010)
A NTIBIOTICS NANOSUSPENSION : A REVIEW
M. Mathew (2017)See more